期刊文献+

吸烟人群细胞色素P4501A1和谷胱甘肽-S-转移酶M1的基因型 被引量:1

Genotypes of cytochrome P4 50 1A1and glutathione-S-transferase M1in smoking people
下载PDF
导出
摘要 采用分子流行病学的方法 ,研究吸烟人群细胞色素 P450 1 A1基因 (CYP1 A1 )和谷胱甘肽 - S-转移酶 M1基因 (GST M1 )的多态性特征 .吸烟人群与同性别及同年龄 (年龄 <2周岁 )健康人群一对一配对 .提取血液基因组 DNA. PCR扩增 CYP 1 A1Exon7位点片段和 GST M1部分片段 .限制性酶切片段长度多态性 (RELP)分析 P450 1 A1片段和GST M1片段多态性特点 .结果显示吸烟组人群中CYP 1 A1 Exon 7Val/Val型 (mm型 )人群数增高 ,并有统计学差异 .吸烟组人群中 :GST M1缺失人群数略有升高 ;CYP1 A1 wm型人群数略有升高 ;CYP 1 A1 wm型 +mm型人群数略有升高 。 The polymorphisms of cyto- chrome P45 0 gene (CYP 1 A1 ) and glu- tathione- S- transferase M1 gene(GST M1 ) were studied.The controls were matched to the cases by same age(± 2 years old) ,same sex,same ethnicity,same living area,with- out the history of smoking,genetic dis- eases,drinking alcohol and other serious diseases. Genomic DNAs were extracted from blood.The CYP 1 A1 and GST M1 ge- netic polymorphisms were determined by PCR approach and RELP,respectively. Odds ratio and95 % confidence interval of these gene polymorphisms were calculated by statistical analysis.The results showed the numbers of CYP 1 A1 exon 7Val/ Val (mm ) polymorphism in smoking people were more than in control people;the num- bers of CYP1 A1 Val/ Ile(mw) ,wm+mm and GST M1 null polymorphisms had some increase in smoking people.
出处 《中国药理学与毒理学杂志》 CSCD 北大核心 2000年第5期383-386,共4页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金资助项目!(39976 0 2 5 ) 国家自然科学基金资助项目!(3940 0 110 )
关键词 吸烟 细胞色素P450 谷胱甘肽转移酶 多态性基因 polymorphism gene smoking cytochrome P45 0 glutathione transferases
  • 相关文献

参考文献3

二级参考文献2

共引文献180

同被引文献13

  • 1谭守勇,林兆原,关玉华,李嫣红,潘爱华,黎燕琼,粱敏青.蛋白质营养不良对抗结核药物肝损害的影响[J].中国防痨杂志,2006,28(2):83-86. 被引量:44
  • 2夏愔愔,詹思延.国内抗结核药物不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423. 被引量:208
  • 3Steele MA, Burk RF, Desprez RM. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest, 1991,99 : 465-471.
  • 4Roy B, Chowdhury A, Kundu S, et al. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1" null" mutation J Gastroenterol Hepatol, 2001,16 : 1033-1037.
  • 5Sun F, Chen Y, Xiang Y, et al. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis. Int J Tuberc Lung Dis, 2008,12: 994-1002.
  • 6Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276.
  • 7Ohno M, Yamaguchi I, Yamamoto I, et al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis, 2000, 4 : 256 -261.
  • 8Lin HJ, Han CY, Bernsteiu DA, et al. Ethnic distribution of the glutathione transferase Mu 1-1 ( GSTM1 ) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis, 1994,15 : 1077-1081.
  • 9Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis, 1995,16: 1243-1245.
  • 10冷曙光,宋文佳,王雅文,谷也平,潘祖飞,肖军,刘玉瑛,郑玉新.中国汉族人口三种谷胱甘肽S转移酶基因多态性分析[J].中华预防医学杂志,2001,35(3):159-162. 被引量:42

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部